Eintrag weiter verarbeiten
author_facet Pesch, Beate
Gawrych, Katarzyna
Rabstein, Sylvia
Weiss, Tobias
Casjens, Swaantje
Rihs, Hans-Peter
Ding, Hui
Angerer, Jürgen
Illig, Thomas
Klopp, Norman
Bueno-de-Mesquita, Bas
Ros, Martine M.
Kaaks, Rudolf
Chang-Claude, Jenny
Roswall, Nina
Tjønneland, Anne
Overvad, Kim
Clavel-Chapelon, Françoise
Boutron-Ruault, Marie-Christine
Dossus, Laure
Boeing, Heiner
Weikert, Steffen
Trichopoulos, Dimitrios
Palli, Domenico
Sieri, Sabina
Tumino, Rosario
Panico, Salvatore
Quirós, José Ramón
González, Carlos
Sánchez, Mariá José
Dorronsoro, Miren
Navarro, Carmen
Barricarte, Aurelio
Ljungberg, Börje
Johansson, Mattias
Ulmert, David
Ehrnström, Roy
Khaw, Kay-Tee
Wareham, Nick
Key, Timothy J.
Ferrari, Pietro
Romieu, Isabelle
Riboli, Elio
Brüning, Thomas
Vineis, Paolo
Pesch, Beate
Gawrych, Katarzyna
Rabstein, Sylvia
Weiss, Tobias
Casjens, Swaantje
Rihs, Hans-Peter
Ding, Hui
Angerer, Jürgen
Illig, Thomas
Klopp, Norman
Bueno-de-Mesquita, Bas
Ros, Martine M.
Kaaks, Rudolf
Chang-Claude, Jenny
Roswall, Nina
Tjønneland, Anne
Overvad, Kim
Clavel-Chapelon, Françoise
Boutron-Ruault, Marie-Christine
Dossus, Laure
Boeing, Heiner
Weikert, Steffen
Trichopoulos, Dimitrios
Palli, Domenico
Sieri, Sabina
Tumino, Rosario
Panico, Salvatore
Quirós, José Ramón
González, Carlos
Sánchez, Mariá José
Dorronsoro, Miren
Navarro, Carmen
Barricarte, Aurelio
Ljungberg, Börje
Johansson, Mattias
Ulmert, David
Ehrnström, Roy
Khaw, Kay-Tee
Wareham, Nick
Key, Timothy J.
Ferrari, Pietro
Romieu, Isabelle
Riboli, Elio
Brüning, Thomas
Vineis, Paolo
author Pesch, Beate
Gawrych, Katarzyna
Rabstein, Sylvia
Weiss, Tobias
Casjens, Swaantje
Rihs, Hans-Peter
Ding, Hui
Angerer, Jürgen
Illig, Thomas
Klopp, Norman
Bueno-de-Mesquita, Bas
Ros, Martine M.
Kaaks, Rudolf
Chang-Claude, Jenny
Roswall, Nina
Tjønneland, Anne
Overvad, Kim
Clavel-Chapelon, Françoise
Boutron-Ruault, Marie-Christine
Dossus, Laure
Boeing, Heiner
Weikert, Steffen
Trichopoulos, Dimitrios
Palli, Domenico
Sieri, Sabina
Tumino, Rosario
Panico, Salvatore
Quirós, José Ramón
González, Carlos
Sánchez, Mariá José
Dorronsoro, Miren
Navarro, Carmen
Barricarte, Aurelio
Ljungberg, Börje
Johansson, Mattias
Ulmert, David
Ehrnström, Roy
Khaw, Kay-Tee
Wareham, Nick
Key, Timothy J.
Ferrari, Pietro
Romieu, Isabelle
Riboli, Elio
Brüning, Thomas
Vineis, Paolo
spellingShingle Pesch, Beate
Gawrych, Katarzyna
Rabstein, Sylvia
Weiss, Tobias
Casjens, Swaantje
Rihs, Hans-Peter
Ding, Hui
Angerer, Jürgen
Illig, Thomas
Klopp, Norman
Bueno-de-Mesquita, Bas
Ros, Martine M.
Kaaks, Rudolf
Chang-Claude, Jenny
Roswall, Nina
Tjønneland, Anne
Overvad, Kim
Clavel-Chapelon, Françoise
Boutron-Ruault, Marie-Christine
Dossus, Laure
Boeing, Heiner
Weikert, Steffen
Trichopoulos, Dimitrios
Palli, Domenico
Sieri, Sabina
Tumino, Rosario
Panico, Salvatore
Quirós, José Ramón
González, Carlos
Sánchez, Mariá José
Dorronsoro, Miren
Navarro, Carmen
Barricarte, Aurelio
Ljungberg, Börje
Johansson, Mattias
Ulmert, David
Ehrnström, Roy
Khaw, Kay-Tee
Wareham, Nick
Key, Timothy J.
Ferrari, Pietro
Romieu, Isabelle
Riboli, Elio
Brüning, Thomas
Vineis, Paolo
Cancer Epidemiology, Biomarkers & Prevention
N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
Oncology
Epidemiology
author_sort pesch, beate
spelling Pesch, Beate Gawrych, Katarzyna Rabstein, Sylvia Weiss, Tobias Casjens, Swaantje Rihs, Hans-Peter Ding, Hui Angerer, Jürgen Illig, Thomas Klopp, Norman Bueno-de-Mesquita, Bas Ros, Martine M. Kaaks, Rudolf Chang-Claude, Jenny Roswall, Nina Tjønneland, Anne Overvad, Kim Clavel-Chapelon, Françoise Boutron-Ruault, Marie-Christine Dossus, Laure Boeing, Heiner Weikert, Steffen Trichopoulos, Dimitrios Palli, Domenico Sieri, Sabina Tumino, Rosario Panico, Salvatore Quirós, José Ramón González, Carlos Sánchez, Mariá José Dorronsoro, Miren Navarro, Carmen Barricarte, Aurelio Ljungberg, Börje Johansson, Mattias Ulmert, David Ehrnström, Roy Khaw, Kay-Tee Wareham, Nick Key, Timothy J. Ferrari, Pietro Romieu, Isabelle Riboli, Elio Brüning, Thomas Vineis, Paolo 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-13-0119-t <jats:title>Abstract</jats:title><jats:p>Background: An association between N-acetyltransferase 2 (NAT2) slow acetylation and bladder cancer has been consistently observed in epidemiologic studies. However, evidence has been mainly derived from case–control studies and was sparse from cohort studies. We evaluated the association between NAT2 slow acetylation and bladder cancer in a case–control study nested in the European Prospective Investigation into Cancer and Nutrition.</jats:p><jats:p>Methods: Exposure to aromatic amines and polycyclic aromatic hydrocarbons (PAH) could be assessed for 754 cases and 833 controls for whom occupational information was documented. A semiquantitative job-exposure matrix was applied to at-risk occupations to estimate the exposure as low, medium, or high based on tertiles of the distribution of the exposure score in controls. Using a comprehensive genotyping, NAT2 acetylation status could be categorized from 6-single-nucleotide polymorphism genotypes as slow or fast in 607 cases and 695 controls with DNA from archived blood samples.</jats:p><jats:p>Results: Occupational exposure to aromatic amines and PAH was associated with an increased bladder cancer risk [upper tertile of the distribution of the exposure score: OR = 1.37; 95% confidence interval (CI), 1.02–1.84, and OR = 1.50; 95% CI, 1.09–2.05, respectively]. NAT2 slow acetylation did not modify these risk estimates and was not itself associated with bladder cancer risk (OR = 1.02; 95% CI, 0.81–1.29).</jats:p><jats:p>Conclusions: These findings confirm established or suspected occupational risk factors but not the anticipated role of NAT2 slow acetylation in bladder cancer. No interaction was detected between NAT2 and any exposure of interest, including smoking.</jats:p><jats:p>Impact: Genetic testing for NAT2 would be inappropriate in occupational settings. Cancer Epidemiol Biomarkers Prev; 22(11); 2055–65. ©2013 AACR.</jats:p> N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort Cancer Epidemiology, Biomarkers & Prevention
doi_str_mv 10.1158/1055-9965.epi-13-0119-t
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTEzLTAxMTktdA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTEzLTAxMTktdA
institution DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint American Association for Cancer Research (AACR), 2013
imprint_str_mv American Association for Cancer Research (AACR), 2013
issn 1538-7755
1055-9965
issn_str_mv 1538-7755
1055-9965
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str pesch2013nacetyltransferase2phenotypeoccupationandbladdercancerriskresultsfromtheepiccohort
publishDateSort 2013
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
title N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_unstemmed N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_full N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_fullStr N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_full_unstemmed N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_short N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_sort n-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the epic cohort
topic Oncology
Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-13-0119-t
publishDate 2013
physical 2055-2065
description <jats:title>Abstract</jats:title><jats:p>Background: An association between N-acetyltransferase 2 (NAT2) slow acetylation and bladder cancer has been consistently observed in epidemiologic studies. However, evidence has been mainly derived from case–control studies and was sparse from cohort studies. We evaluated the association between NAT2 slow acetylation and bladder cancer in a case–control study nested in the European Prospective Investigation into Cancer and Nutrition.</jats:p><jats:p>Methods: Exposure to aromatic amines and polycyclic aromatic hydrocarbons (PAH) could be assessed for 754 cases and 833 controls for whom occupational information was documented. A semiquantitative job-exposure matrix was applied to at-risk occupations to estimate the exposure as low, medium, or high based on tertiles of the distribution of the exposure score in controls. Using a comprehensive genotyping, NAT2 acetylation status could be categorized from 6-single-nucleotide polymorphism genotypes as slow or fast in 607 cases and 695 controls with DNA from archived blood samples.</jats:p><jats:p>Results: Occupational exposure to aromatic amines and PAH was associated with an increased bladder cancer risk [upper tertile of the distribution of the exposure score: OR = 1.37; 95% confidence interval (CI), 1.02–1.84, and OR = 1.50; 95% CI, 1.09–2.05, respectively]. NAT2 slow acetylation did not modify these risk estimates and was not itself associated with bladder cancer risk (OR = 1.02; 95% CI, 0.81–1.29).</jats:p><jats:p>Conclusions: These findings confirm established or suspected occupational risk factors but not the anticipated role of NAT2 slow acetylation in bladder cancer. No interaction was detected between NAT2 and any exposure of interest, including smoking.</jats:p><jats:p>Impact: Genetic testing for NAT2 would be inappropriate in occupational settings. Cancer Epidemiol Biomarkers Prev; 22(11); 2055–65. ©2013 AACR.</jats:p>
container_issue 11
container_start_page 2055
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 22
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348106070687749
geogr_code not assigned
last_indexed 2024-03-01T18:05:53.076Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=N-acetyltransferase+2+Phenotype%2C+Occupation%2C+and+Bladder+Cancer+Risk%3A+Results+from+the+EPIC+Cohort&rft.date=2013-11-01&genre=article&issn=1538-7755&volume=22&issue=11&spage=2055&epage=2065&pages=2055-2065&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=N-acetyltransferase+2+Phenotype%2C+Occupation%2C+and+Bladder+Cancer+Risk%3A+Results+from+the+EPIC+Cohort&aulast=Vineis&aufirst=Paolo&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-13-0119-t&rft.language%5B0%5D=eng
SOLR
_version_ 1792348106070687749
author Pesch, Beate, Gawrych, Katarzyna, Rabstein, Sylvia, Weiss, Tobias, Casjens, Swaantje, Rihs, Hans-Peter, Ding, Hui, Angerer, Jürgen, Illig, Thomas, Klopp, Norman, Bueno-de-Mesquita, Bas, Ros, Martine M., Kaaks, Rudolf, Chang-Claude, Jenny, Roswall, Nina, Tjønneland, Anne, Overvad, Kim, Clavel-Chapelon, Françoise, Boutron-Ruault, Marie-Christine, Dossus, Laure, Boeing, Heiner, Weikert, Steffen, Trichopoulos, Dimitrios, Palli, Domenico, Sieri, Sabina, Tumino, Rosario, Panico, Salvatore, Quirós, José Ramón, González, Carlos, Sánchez, Mariá José, Dorronsoro, Miren, Navarro, Carmen, Barricarte, Aurelio, Ljungberg, Börje, Johansson, Mattias, Ulmert, David, Ehrnström, Roy, Khaw, Kay-Tee, Wareham, Nick, Key, Timothy J., Ferrari, Pietro, Romieu, Isabelle, Riboli, Elio, Brüning, Thomas, Vineis, Paolo
author_facet Pesch, Beate, Gawrych, Katarzyna, Rabstein, Sylvia, Weiss, Tobias, Casjens, Swaantje, Rihs, Hans-Peter, Ding, Hui, Angerer, Jürgen, Illig, Thomas, Klopp, Norman, Bueno-de-Mesquita, Bas, Ros, Martine M., Kaaks, Rudolf, Chang-Claude, Jenny, Roswall, Nina, Tjønneland, Anne, Overvad, Kim, Clavel-Chapelon, Françoise, Boutron-Ruault, Marie-Christine, Dossus, Laure, Boeing, Heiner, Weikert, Steffen, Trichopoulos, Dimitrios, Palli, Domenico, Sieri, Sabina, Tumino, Rosario, Panico, Salvatore, Quirós, José Ramón, González, Carlos, Sánchez, Mariá José, Dorronsoro, Miren, Navarro, Carmen, Barricarte, Aurelio, Ljungberg, Börje, Johansson, Mattias, Ulmert, David, Ehrnström, Roy, Khaw, Kay-Tee, Wareham, Nick, Key, Timothy J., Ferrari, Pietro, Romieu, Isabelle, Riboli, Elio, Brüning, Thomas, Vineis, Paolo, Pesch, Beate, Gawrych, Katarzyna, Rabstein, Sylvia, Weiss, Tobias, Casjens, Swaantje, Rihs, Hans-Peter, Ding, Hui, Angerer, Jürgen, Illig, Thomas, Klopp, Norman, Bueno-de-Mesquita, Bas, Ros, Martine M., Kaaks, Rudolf, Chang-Claude, Jenny, Roswall, Nina, Tjønneland, Anne, Overvad, Kim, Clavel-Chapelon, Françoise, Boutron-Ruault, Marie-Christine, Dossus, Laure, Boeing, Heiner, Weikert, Steffen, Trichopoulos, Dimitrios, Palli, Domenico, Sieri, Sabina, Tumino, Rosario, Panico, Salvatore, Quirós, José Ramón, González, Carlos, Sánchez, Mariá José, Dorronsoro, Miren, Navarro, Carmen, Barricarte, Aurelio, Ljungberg, Börje, Johansson, Mattias, Ulmert, David, Ehrnström, Roy, Khaw, Kay-Tee, Wareham, Nick, Key, Timothy J., Ferrari, Pietro, Romieu, Isabelle, Riboli, Elio, Brüning, Thomas, Vineis, Paolo
author_sort pesch, beate
container_issue 11
container_start_page 2055
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 22
description <jats:title>Abstract</jats:title><jats:p>Background: An association between N-acetyltransferase 2 (NAT2) slow acetylation and bladder cancer has been consistently observed in epidemiologic studies. However, evidence has been mainly derived from case–control studies and was sparse from cohort studies. We evaluated the association between NAT2 slow acetylation and bladder cancer in a case–control study nested in the European Prospective Investigation into Cancer and Nutrition.</jats:p><jats:p>Methods: Exposure to aromatic amines and polycyclic aromatic hydrocarbons (PAH) could be assessed for 754 cases and 833 controls for whom occupational information was documented. A semiquantitative job-exposure matrix was applied to at-risk occupations to estimate the exposure as low, medium, or high based on tertiles of the distribution of the exposure score in controls. Using a comprehensive genotyping, NAT2 acetylation status could be categorized from 6-single-nucleotide polymorphism genotypes as slow or fast in 607 cases and 695 controls with DNA from archived blood samples.</jats:p><jats:p>Results: Occupational exposure to aromatic amines and PAH was associated with an increased bladder cancer risk [upper tertile of the distribution of the exposure score: OR = 1.37; 95% confidence interval (CI), 1.02–1.84, and OR = 1.50; 95% CI, 1.09–2.05, respectively]. NAT2 slow acetylation did not modify these risk estimates and was not itself associated with bladder cancer risk (OR = 1.02; 95% CI, 0.81–1.29).</jats:p><jats:p>Conclusions: These findings confirm established or suspected occupational risk factors but not the anticipated role of NAT2 slow acetylation in bladder cancer. No interaction was detected between NAT2 and any exposure of interest, including smoking.</jats:p><jats:p>Impact: Genetic testing for NAT2 would be inappropriate in occupational settings. Cancer Epidemiol Biomarkers Prev; 22(11); 2055–65. ©2013 AACR.</jats:p>
doi_str_mv 10.1158/1055-9965.epi-13-0119-t
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTEzLTAxMTktdA
imprint American Association for Cancer Research (AACR), 2013
imprint_str_mv American Association for Cancer Research (AACR), 2013
institution DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1538-7755, 1055-9965
issn_str_mv 1538-7755, 1055-9965
language English
last_indexed 2024-03-01T18:05:53.076Z
match_str pesch2013nacetyltransferase2phenotypeoccupationandbladdercancerriskresultsfromtheepiccohort
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 2055-2065
publishDate 2013
publishDateSort 2013
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
spelling Pesch, Beate Gawrych, Katarzyna Rabstein, Sylvia Weiss, Tobias Casjens, Swaantje Rihs, Hans-Peter Ding, Hui Angerer, Jürgen Illig, Thomas Klopp, Norman Bueno-de-Mesquita, Bas Ros, Martine M. Kaaks, Rudolf Chang-Claude, Jenny Roswall, Nina Tjønneland, Anne Overvad, Kim Clavel-Chapelon, Françoise Boutron-Ruault, Marie-Christine Dossus, Laure Boeing, Heiner Weikert, Steffen Trichopoulos, Dimitrios Palli, Domenico Sieri, Sabina Tumino, Rosario Panico, Salvatore Quirós, José Ramón González, Carlos Sánchez, Mariá José Dorronsoro, Miren Navarro, Carmen Barricarte, Aurelio Ljungberg, Börje Johansson, Mattias Ulmert, David Ehrnström, Roy Khaw, Kay-Tee Wareham, Nick Key, Timothy J. Ferrari, Pietro Romieu, Isabelle Riboli, Elio Brüning, Thomas Vineis, Paolo 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-13-0119-t <jats:title>Abstract</jats:title><jats:p>Background: An association between N-acetyltransferase 2 (NAT2) slow acetylation and bladder cancer has been consistently observed in epidemiologic studies. However, evidence has been mainly derived from case–control studies and was sparse from cohort studies. We evaluated the association between NAT2 slow acetylation and bladder cancer in a case–control study nested in the European Prospective Investigation into Cancer and Nutrition.</jats:p><jats:p>Methods: Exposure to aromatic amines and polycyclic aromatic hydrocarbons (PAH) could be assessed for 754 cases and 833 controls for whom occupational information was documented. A semiquantitative job-exposure matrix was applied to at-risk occupations to estimate the exposure as low, medium, or high based on tertiles of the distribution of the exposure score in controls. Using a comprehensive genotyping, NAT2 acetylation status could be categorized from 6-single-nucleotide polymorphism genotypes as slow or fast in 607 cases and 695 controls with DNA from archived blood samples.</jats:p><jats:p>Results: Occupational exposure to aromatic amines and PAH was associated with an increased bladder cancer risk [upper tertile of the distribution of the exposure score: OR = 1.37; 95% confidence interval (CI), 1.02–1.84, and OR = 1.50; 95% CI, 1.09–2.05, respectively]. NAT2 slow acetylation did not modify these risk estimates and was not itself associated with bladder cancer risk (OR = 1.02; 95% CI, 0.81–1.29).</jats:p><jats:p>Conclusions: These findings confirm established or suspected occupational risk factors but not the anticipated role of NAT2 slow acetylation in bladder cancer. No interaction was detected between NAT2 and any exposure of interest, including smoking.</jats:p><jats:p>Impact: Genetic testing for NAT2 would be inappropriate in occupational settings. Cancer Epidemiol Biomarkers Prev; 22(11); 2055–65. ©2013 AACR.</jats:p> N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort Cancer Epidemiology, Biomarkers & Prevention
spellingShingle Pesch, Beate, Gawrych, Katarzyna, Rabstein, Sylvia, Weiss, Tobias, Casjens, Swaantje, Rihs, Hans-Peter, Ding, Hui, Angerer, Jürgen, Illig, Thomas, Klopp, Norman, Bueno-de-Mesquita, Bas, Ros, Martine M., Kaaks, Rudolf, Chang-Claude, Jenny, Roswall, Nina, Tjønneland, Anne, Overvad, Kim, Clavel-Chapelon, Françoise, Boutron-Ruault, Marie-Christine, Dossus, Laure, Boeing, Heiner, Weikert, Steffen, Trichopoulos, Dimitrios, Palli, Domenico, Sieri, Sabina, Tumino, Rosario, Panico, Salvatore, Quirós, José Ramón, González, Carlos, Sánchez, Mariá José, Dorronsoro, Miren, Navarro, Carmen, Barricarte, Aurelio, Ljungberg, Börje, Johansson, Mattias, Ulmert, David, Ehrnström, Roy, Khaw, Kay-Tee, Wareham, Nick, Key, Timothy J., Ferrari, Pietro, Romieu, Isabelle, Riboli, Elio, Brüning, Thomas, Vineis, Paolo, Cancer Epidemiology, Biomarkers & Prevention, N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort, Oncology, Epidemiology
title N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_full N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_fullStr N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_full_unstemmed N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_short N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
title_sort n-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the epic cohort
title_unstemmed N-acetyltransferase 2 Phenotype, Occupation, and Bladder Cancer Risk: Results from the EPIC Cohort
topic Oncology, Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-13-0119-t